Yip D, Zalcberg J, Blay JY, Eriksson M, Espinoza D, Price T, Marreaud S, Italiano A, Steeghs N, Boye K, Underhill C, Gebski V, Simes J, Gelderblom H, Joensuu H (2025)
Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trial
Br J Cancer (in press)
DOI 10.1038/s41416-025-02983-w, PubMed 40133509

Naolou T, Schadzek N, Hornbostel JM, Pepelanova I, Frommer M, Lötz F, Sauheitl L, Dultz S, Felde VJMNL, Myklebost O, Lee-Thedieck C (2025)
Enhanced gelatin methacryloyl nanohydroxyapatite hydrogel for high-fidelity 3D printing of bone tissue engineering scaffolds
Biofabrication, 17 (2)
DOI 10.1088/1758-5090/adbb90, PubMed 40020249

Song L, Kostas M, Laerdahl JK, Skálová M, Janská T, Juzeniene A, Ræstad S, Krivokapic A, Kalantzopoulos GN, Soltes J, Vlk M, Kozempel J, Hassfjell S, Wesche J (2025)
Preparation and Characterization of an Engineered FGF1 Conjugated to ¹⁶¹Tb for Targeting of FGFRs
ACS Omega, 10 (6), 5730-5743
DOI 10.1021/acsomega.4c09179, PubMed 39989790